US Patent 8207177 Inhibitors of E1 activating enzymes
Patent 8207177 was granted and assigned to Millennium Pharmaceuticals on June, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+390 characters)
Article
Patent abstract
This invention relates to compounds that inhibit E1 activating enzymes, pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating disorders, particularly cell proliferation disorders, including cancers, inflammatory and neurodegenerative disorders; and inflammation associated with infection and cachexia.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Edward J. Olhava0
Stepan Vyskocil0
Steven P. Langston0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08207177 Inhibitors of E1 activating enzymes US Patent 8207177 Inhibitors of E1 activating enzymes
Infobox
Patent Number
082071770
Patent Number
82071770
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
082071770
Date of Patent
June 26, 2012
0Patent Application Number
117006140
Date Filed
January 31, 2007
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08207177 Inhibitors of E1 activating enzymes
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08207177
Date of patent
June 26, 2012
Patent application number
11700614
Date Filed
January 31, 2007
Patent primary examiner
Find more entities like US Patent 8207177 Inhibitors of E1 activating enzymes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
